What does CUSIP 04683R106 represent in this 13F holders report?

CUSIP 04683R106 is the security identifier for AVIR - Atea Pharmaceuticals, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AVIR - Atea Pharmaceuticals, Inc. - Common Stock in Q2 2022?

122 institutional investors reported AVIR - Atea Pharmaceuticals, Inc. - Common Stock for Q2 2022. Use the holders table for investor-level position and value details.

Atea Pharmaceuticals, Inc. - Common Stock (AVIR)

CUSIP: 04683R106

Q2 2022 13F Holders as of 30 Jun 2022

Type / Class: Equity / Common Stock
Shares outstanding: 78,888,889
Total 13F shares: 57,566,762
Share change: +2,755,217
Total reported value: $408,727,109
Put/Call ratio: 9%
Price per share: $7.10
Number of holders: 122
Value change: +$19,469,875
Number of buys: 58
Number of sells: 56

Quarterly Holders Quick Answers

What is CUSIP 04683R106?
CUSIP 04683R106 identifies AVIR - Atea Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2022
Previous quarter: Q1 2022

Recent filing periods for CUSIP 04683R106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AVIR - Atea Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	16%	12,579,791	$90,826,000	—	31 Mar 2022	13F
VANGUARD GROUP INC	13F	Company	8.5%	6,729,203	$48,584,000	—	31 Mar 2022	13F
BlackRock Finance, Inc.	13F	Company	8.4%	6,624,693	$47,830,000	—	31 Mar 2022	13F
EcoR1 Capital, LLC	13F	Company	8%	6,340,639	$45,779,000	—	31 Mar 2022	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	3.2%	2,485,638	$17,946,000	—	31 Mar 2022	13F
FEDERATED HERMES, INC.	13F	Company	2.6%	2,051,332	$14,812,000	—	31 Mar 2022	13F
STATE STREET CORP	13F	Company	2.4%	1,872,074	$13,516,000	—	31 Mar 2022	13F
CITADEL ADVISORS LLC	13F	Company	2%	1,554,225	$11,221,000	—	31 Mar 2022	13F
Cormorant Asset Management, LP	13F	Company	2%	1,547,181	$11,171,000	—	31 Mar 2022	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	1.5%	1,165,000	$8,411,000	—	31 Mar 2022	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	1,028,760	$7,427,000	—	31 Mar 2022	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	1.1%	852,576	$6,152,000	—	31 Mar 2022	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	1%	815,277	$5,886,000	—	31 Mar 2022	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.76%	602,002	$4,346,000	—	31 Mar 2022	13F
NORTHERN TRUST CORP	13F	Company	0.71%	560,020	$4,043,000	—	31 Mar 2022	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.57%	447,115	$3,228,000	—	31 Mar 2022	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.57%	445,960	$3,220,000	—	31 Mar 2022	13F
MORGAN STANLEY	13F	Company	0.54%	428,562	$3,095,000	—	31 Mar 2022	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.53%	414,597	$2,994,000	—	31 Mar 2022	13F
BANQUE PICTET & CIE SA	13F	Company	0.44%	345,077	$2,491,000	—	31 Mar 2022	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.36%	281,475	$2,032,000	—	31 Mar 2022	13F
Bank of New York Mellon Corp	13F	Company	0.35%	276,726	$1,998,000	—	31 Mar 2022	13F
JUPITER ASSET MANAGEMENT LTD	13F	Company	0.34%	270,540	$1,948,000	—	31 Mar 2022	13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE	13F	Company	0.33%	258,655	$1,861,676	—	31 Mar 2022	13F
DEUTSCHE BANK AG\	13F	Company	0.31%	246,794	$1,782,000	—	31 Mar 2022	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	253,013	$1,753,000	—	31 Mar 2022	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.29%	231,925	$1,674,000	—	31 Mar 2022	13F
PDT Partners, LLC	13F	Company	0.28%	224,660	$1,622,000	—	31 Mar 2022	13F
JPMORGAN CHASE & CO	13F	Company	0.28%	219,600	$1,586,000	—	31 Mar 2022	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.26%	201,693	$1,456,000	—	31 Mar 2022	13F
CM Management, LLC	13F	Company	0.25%	200,000	$1,444,000	—	31 Mar 2022	13F
CONGRESS ASSET MANAGEMENT CO	13F	Company	0.23%	181,135	$1,308,000	—	31 Mar 2022	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.21%	163,800	$1,183,000	—	31 Mar 2022	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.19%	153,605	$1,109,000	—	31 Mar 2022	13F
MARTINGALE ASSET MANAGEMENT L P	13F	Company	0.19%	146,128	$1,056,000	—	31 Mar 2022	13F
Cubist Systematic Strategies, LLC	13F	Company	0.16%	124,540	$899,000	—	31 Mar 2022	13F
STRS OHIO	13F	Company	0.16%	123,700	$893,000	—	31 Mar 2022	13F
SIMPLEX TRADING, LLC	13F	Company	0.15%	117,345	$847,000	—	31 Mar 2022	13F
JANE STREET GROUP, LLC	13F	Company	0.14%	113,029	$816,000	—	31 Mar 2022	13F
Invesco Ltd.	13F	Company	0.13%	105,018	$758,000	—	31 Mar 2022	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.13%	104,789	$742,000	—	31 Mar 2022	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.12%	97,300	$703,000	—	31 Mar 2022	13F
GROUP ONE TRADING LLC	13F	Company	0.12%	96,049	$693,000	—	31 Mar 2022	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.11%	88,341	$637,000	—	31 Mar 2022	13F
RHUMBLINE ADVISERS	13F	Company	0.1%	82,237	$594,000	—	31 Mar 2022	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.1%	80,100	$578,000	—	31 Mar 2022	13F
Graham Capital Management, L.P.	13F	Company	0.1%	75,817	$547,000	—	31 Mar 2022	13F
MACQUARIE GROUP LTD	13F	Company	0.09%	71,504	$516,000	—	31 Mar 2022	13F
BARCLAYS PLC	13F	Company	0.08%	62,010	$448,000	—	31 Mar 2022	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.08%	59,424	$429,000	—	31 Mar 2022	13F

Institutional Holders of Atea Pharmaceuticals, Inc. - Common Stock (AVIR) as of Q2 2022

As of 30 Jun 2022, Atea Pharmaceuticals, Inc. - Common Stock (AVIR) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 57,566,762 shares. The largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, EcoR1 Capital, LLC, FEDERATED HERMES, INC., Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, Balyasny Asset Management LLC, K2 PRINCIPAL FUND, L.P., and Cormorant Asset Management, LP. This page lists 123 institutional shareholders reporting positions in this security for the Q2 2022 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2022 vs Q1 2022 Across Filers

Q1 2022 holders

121

Q2 2022 holders

122

Holder diff

Investor	Q1 2022 Shares	Q2 2022 Shares	Share Diff	Share Chg %	Q1 2022 Value $	Q2 2022 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.